Uloric Gout Medication Warning
Have you or a loved one suffered a heart attack, stroke, or died while taking Uloric to treat gout?
The FDA recently warned that patients taking the gout medication Uloric (febuxostat) face an increased risk of serious injuries or illness. Uloric injuries have included
- Heart Attack
- Stroke, and
FDA Claims Uloric to be Dangerous
In February 2019, the FDA issued a statement addressing the potential dangers associated with Uloric (generic name, febuxostat). Uloric is a medication used to treat gout.
The FDA has been investigating the potential link between Uloric and severe side-effects since 2017.
In the statement, the FDA concluded that there is an increased risk of death associated with Uloric when compared to another gout medicine called allopurinol. Specifically, they found an increased risk of heart-related death, as well as death from other causes associated with Uloric.
In patients treated with Uloric, 15 deaths from heart-related causes were observed for every 1,000 patients treated for one year. In addition, there were 26 deaths from any cause per 1,000 patients treated for one year with Uloric.
As a result of this study, the FDA is now requiring the makers of Uloric, Takeda Pharmaceuticals, to include what is known as a black boxed warning on their medication, as well as an updated medication guide to alert doctors and patients of the potential risks associated with Uloric.
We are reviewing Uloric Injury cases. Call for a Free Consultation.